DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Bank of New York Mellon Corp

Posted by Defense World Staff on Mar 10th, 2023

Bank of New York Mellon Corp cut its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 1.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,128,843 shares of the medical instruments supplier’s stock after selling 24,877 shares during the period. Bank of New York Mellon Corp owned 0.99% of DENTSPLY SIRONA worth $60,352,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Wipfli Financial Advisors LLC acquired a new position in DENTSPLY SIRONA in the third quarter valued at approximately $27,000. Riverview Trust Co lifted its holdings in DENTSPLY SIRONA by 185.6% in the third quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 644 shares during the last quarter. SRS Capital Advisors Inc. acquired a new position in DENTSPLY SIRONA in the third quarter valued at approximately $28,000. Ellevest Inc. lifted its holdings in DENTSPLY SIRONA by 281.2% in the third quarter. Ellevest Inc. now owns 1,216 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 897 shares during the last quarter. Finally, SJS Investment Consulting Inc. acquired a new position in DENTSPLY SIRONA in the third quarter valued at approximately $35,000. 98.52% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Morgan Stanley decreased their price objective on DENTSPLY SIRONA from $42.00 to $39.00 and set an “overweight” rating on the stock in a report on Tuesday, November 15th. Barrington Research upped their price target on DENTSPLY SIRONA from $40.00 to $43.00 in a research note on Wednesday, March 1st. Robert W. Baird decreased their price target on DENTSPLY SIRONA to $32.00 in a research note on Thursday, November 17th. William Blair upgraded DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a research note on Wednesday, January 11th. Finally, TheStreet upgraded DENTSPLY SIRONA from a “d+” rating to a “c” rating in a research note on Tuesday, February 28th. Seven research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and a consensus price target of $39.33.

Insider Activity at DENTSPLY SIRONA

In related news, SVP Cord Friedrich Staehler sold 4,000 shares of the stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $39.33, for a total value of $157,320.00. Following the transaction, the senior vice president now owns 97,693 shares of the company’s stock, valued at $3,842,265.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.76% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Stock Down 2.3 %

DENTSPLY SIRONA stock opened at $37.09 on Friday. DENTSPLY SIRONA Inc. has a twelve month low of $26.48 and a twelve month high of $51.19. The stock’s fifty day simple moving average is $36.24 and its 200-day simple moving average is $32.65. The company has a current ratio of 1.62, a quick ratio of 1.08 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $7.99 billion, a P/E ratio of 14.21, a P/E/G ratio of 2.29 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last posted its earnings results on Tuesday, February 28th. The medical instruments supplier reported $0.46 EPS for the quarter, beating the consensus estimate of $0.32 by $0.14. The firm had revenue of $983.00 million for the quarter, compared to analyst estimates of $939.11 million. DENTSPLY SIRONA had a positive return on equity of 8.71% and a negative net margin of 24.35%. DENTSPLY SIRONA’s revenue for the quarter was down 10.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.76 earnings per share. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.87 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 14th. Investors of record on Friday, March 31st will be issued a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 1.35%. The ex-dividend date is Thursday, March 30th.

About DENTSPLY SIRONA

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.